Procalcitonin as a Marker of Infection in Cancer Patients

Clinical trial NCT01227109 · UNKNOWN

Trial details

NCT number: NCT01227109
Sponsor: Herlev Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Infections Cancer Procalcitonin C Reactive Protein

Start date: 2011-02-01
Primary completion: 2012-02-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.